Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
XPEV · NYSE · United States · Motor Vehicles & Passenger Car Bodies
In shortXPENG INC. is loss-making, generates cash and holds more cash than debt, with revenue growing (+87.7% last year).
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it.
| Operating marginShare of each sale left after running the business, before interest and tax. | -3.6% | 5/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -1.5% | 14/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -3.7% | 0/100 |
| Return on invested capitalProfit earned on all the capital used (equity and debt). Above 10% usually means a real competitive edge. | -5.1% | 0/100 |
Weight in the score: 25%
| Current ratioShort-term assets divided by short-term debts. Below 1 can mean tight cash. | 1.09× | 24/100 |
|---|---|---|
| Debt / equityDebt compared with the shareholders' stake. Above 2 is heavily indebted. | 0.42× | 88/100 |
| Net debt / EBITDAYears of operating profit needed to repay net debt. Below 2 is comfortable. | Net cash | 100/100 |
| Interest coverageHow many times operating profit covers interest. Below 2 is risky. | -7.29× | 0/100 |
| Altman Z''Bankruptcy-risk model. Above 2.6 safe, below 1.1 distress. | -0.77 | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | 6.7% | 47/100 |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 1 of 5 | 0/100 |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 0 of 5 | 100/100 |
| Revenue growth volatility | 101.6% | 0/100 |
| Operating margin volatility | 13.5% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 41.9% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
3 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
CNY millions; negative values in parentheses.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 20,988 | 26,855 | 30,676 | 40,866 | 76,720 |
| Cost of revenue | 18,366 | 23,767 | 30,225 | 35,021 | 62,247 |
| Gross profit | 2,623 | 3,088 | 451 | 5,846 | 14,473 |
| Research & development | 4,114 | 5,215 | 5,277 | 6,457 | 9,490 |
| Selling, general & admin | 5,305 | 6,688 | 6,559 | 6,871 | 9,398 |
| Operating income | (6,579) | (8,706) | (10,889) | (6,658) | (2,771) |
| Interest expense | 55 | 132 | 269 | 344 | 380 |
| Pre-tax income | (4,837) | (9,118) | (10,394) | (5,831) | (1,157) |
| Income tax | 26 | 25 | 37 | (70) | 14 |
| Net income | (4,863) | (9,139) | (10,376) | (5,790) | (1,139) |
| Diluted EPS | −¥2.96 | −¥5.34 | −¥5.96 | −¥3.06 | −¥0.60 |
| Diluted shares (millions) | 1,643 | 1,713 | 1,741 | 1,891 | 1,904 |
3 older years available with the 10-year history. Essential plan, from €8.25/month →
−0.77 Distress zone
Estimates bankruptcy risk from working capital, retained earnings, operating profit and equity. Above 2.6 is considered safe, below 1.1 signals distress.
6/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Dec 31, 2025 · Data updated Apr 16, 2026